Benco Dental announces strategic partnership with StellaLife

March 28, 2019

The biotech company has a mission to improve people’s lives by reducing the need for narcotic pain medications and antibiotics.

Benco Dental announces a partnership with StellaLife®, an innovative biotech company on a mission to improve people’s lives and significantly reduce, or in some cases eliminate, the need for narcotic pain medications, steroids and antibiotics.

StellaLife is an Illinois-based company that focuses on Intelligent Healing by using ingredients from botanical plants and minerals in an attempt to limit toxins and ensure good health for all patients. The company has worked with leading chemists, dental specialists, physicians and pharmacists to create a line of products that aim to improve dental patients’ experience.

“The clinically proven StellaLife product line encompasses a broad spectrum of applications, ranging from recovery to maintenance, and from the treatment of oral inflammatory conditions to pain management,” says Debbie Durako, StellaLife director.

Read more: Benco Dental announces distribution agreement with Align Technology

“We are excited to bring StellaLife's innovative program to Benco customers to improve the well-being of patients and improve surgical and non-surgical outcomes,” Durako adds.

StellaLife's natural approach reportedly allows patients to have an effective alternative to traditional products for oral health.

“Benco is incredibly excited to partner with StellaLife and offer their oral health and pain management solutions to help improve dental patients’ experiences,” says Colette Wintersteen, Benco product manager.

For details, visit benco.com or call 800-GO-BENCO.